Over the last year, the world has witnessed the importance of strong innovation policies as intellectual property protection and market access policies facilitated the research, development and distribution of COVID-19 diagnostics, treatments and vaccines. Innovative medicines are now making their way to patients around the world, demonstrating remarkable progress and collaboration at a scale that was unimaginable at the start of the pandemic, including more than 200 manufacturing and other partnerships to date.